Drugs / TC-325
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02135627 Comparator | Apr 2014 → Jul 2016 | esophageal varices with bleeding | McGill University Health Centre/Research Institute of the McGill University Health Centre | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TC-325 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02135627 ↗ |
| Known as | Hemospray | “TC-325 (Hemospray; Cook Medical, Winston-Salem, NC, USA), an endoscopic hemostatic powder” PMID 31437456 ↗ Aug 2019 |